About CancerX

Announced by the White House Cancer Moonshot in February, CancerX is a public-private partnership to boost innovation in the fight against cancer. Co-hosted by the Moffitt Cancer Center and Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH), it convenes the many diverse stakeholders needed to unleash the power of innovation to reduce the burden of cancer for everyone. To learn more or participate in CancerX’s pre-competitive, evidence-generating efforts, Accelerator cohort, or demonstration projects, sign up today.


To unite a diverse and inclusive community of stakeholders and harness our collective superpowers to rapidly pioneer and equitably deploy innovative solutions that can prevent and cure cancer.


To convene the many stakeholders necessary to create, foster, accelerate, and scale the impact of a community of innovators dedicated to reducing the burden of cancer for all people.

Our Approach

CancerX will ignite innovation in pursuit of the promise of a life without cancer through an integrated, three-pronged approach:

Pre-Competitive Evidence Generation

A rolling series of multi-stakeholder initiatives will develop evidence, best practices, toolkits, and value models to drive the success of the mission.

This program will provide mentorship, education, and exposure to funding and clinical partnership opportunities to a start-up cohort aligned with the mission.

These implementation projects will pilot novel, mission-aligned approaches to demonstrate their value and sustainability for scale to drive broad adoption.

Through this approach, we will establish best practices, build capacity, and demonstrate the impact of innovation on the life of every person on a cancer journey.

2023-2024 Strategic Approach

Demonstrate CancerX as the global leader in advancing digital innovation in oncology in alignment with the goals of the reignited Cancer Moonshot.
Activate the ecosystem by fostering a dynamic innovator community for collaborative knowledge sharing, leveraging national platforms and US government partnerships to enhance outcomes through combined public and private sector strengths.
Identify, support, grow, and implement world-class digital solutions in the market dedicated to reducing the burden of cancer for all people.

Our History

In early 2022, President Biden reignited the Cancer Moonshot, setting new national goals to cut the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer. In its first year, the reignited Cancer Moonshot announced over 25 new programs, policies, and resources in pursuit of these goals.

In February 2023, to mark the one-year anniversary of the new national goals, the Cancer Cabinet – the expert and interagency body responsible for setting the Cancer Moonshot agenda across government agencies – announced three new actions, including the establishment of CancerX – a public-private partnership (PPP) to act as a national accelerator to boost innovation in the fight against cancer.

Read More

Bringing together the elite experience of both digital medicine and oncology, the ONC and OASH are partnering with DiMe and Moffitt Cancer Center to co-host CancerX. The DiMe-Moffitt partnership is well established with a proven track record of success convening multi-stakeholder experts, including government partners, to advance the use of digital solutions to reduce the incidence and burden of cancer for all people.


Agenda | Participants



Advancing digital health innovation in oncology to improve the lives of cancer patients



Reporting a multi-stakeholder driven roadmap for digital innovation in oncology

Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care



Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care

February 2023

Whitehouse Announces CancerX

October 2023

CancerX to Announce Accelerator Cohort

March 2023

CancerX Announces First Project

April 2024

CancerX to Announce First Demonstration Project

Impact Supporter

Impact Supporter Innsena

Our Founding Members

In June 2023, CancerX announced 90+ founding members who were the very first leaders to commit to driving the success of CancerX to achieve the goals of the Cancer Moonshot.

Atrium Health UPDATED
Bulldog Med
Colorado Gov
MEND Nutrition
Orchid Healthcare Solutions Logo 2023 UPDATED
Rubix Updated
Slope Updated
Soteria Updated
Touch BBCA
Volpara Updated

Members also include the National Cancer Institute 

Work is Already Underway!

Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research.